34
Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543 [email protected]

Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Embed Size (px)

Citation preview

Page 1: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Molecular Mechanism of Metabolic disorders

Shinichi Oka, PhD

Department of Cell Biology and Molecular Medicine

Rutgers New Jersey Medical School

MSB-I543

[email protected]

Page 2: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Objectives

Leptin Resistance

Obese

Insulin Resistance

Diabetes

To understand molecular pathology of obesity and diabetes

1. Leptin Resistance as a mechanism of obesity2. Insulin Resistance as a mechanism of diabetes3. Metaflammation link between obesity and diabetes

Metaflammation

Page 3: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Objectives

Leptin Resistance

Obese

Insulin Resistance

Diabetes

To understand molecular pathology of obesity and diabetes

1. Leptin Resistance as a mechanism of obesity2. Insulin Resistance as a mechanism of diabetes3. Metaflammation link between obesity and diabetes

Metaflammation

Page 4: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin resistance causes obesity

ob/ob

ob/ob; Letpin mutant

db/db; Letpin receptor mutant

control

Page 5: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin

Leptin (Greek λεπτός (leptos) meaning "thin") is a 16-kDa adipokine

Adipose tissue

Leptin

Excessive food intake

Brain

Bloodstream

Anorexigenic peptide hormone

Orexigenic peptide hormone

Reduction of appetite

Page 6: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin signalingLeptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Page 7: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Leptin function and signaling

Adipose tissue

Excessive food intake

Brain

Leptin Reduction of appetite

Bloodstream

Page 8: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Molecular pathology of Leptin Resistance

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Ren et al, JCI, 2007Ren et al, Cell Metabolism, 2005

Leptin Resistance

Page 9: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin-induced JAK2 activation is impaired in Leptin Resistance

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Ren et al, JCI, 2007Ren et al, Cell Metabolism, 2005

Leptin Resistance

Page 10: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Ren et al, JCI, 2007Ren et al, Cell Metabolism, 2005

Leptin Resistance

Leptin-induced STAT3 phosphorylation is impaired in Leptin Resistance

Page 11: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Ren et al, JCI, 2007Ren et al, Cell Metabolism, 2005

Orexigenic peptide hormones are elevated in Leptin Resistance

Leptin Resistance

Page 12: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Ren et al, JCI, 2007Ren et al, Cell Metabolism, 2005

Food intake is enhanced in Leptin Resistance

Leptin Resistance

Page 13: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Ren et al, JCI, 2007Ren et al, Cell Metabolism, 2005

Plasma Leptin is elevated in Leptin Resistance

Leptin Resistance

Page 14: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Leptin

JAK2

Anorexigenic peptide hormone

Orexigenic peptide hormone

STAT3

STAT3

STAT3

Plasma membrane

PP

P

P

Nucleus

Appetite

Impaired cellular Leptin signalingIncreased orexinenic peptide hormonesReduced anorexigenic peptide hormonesIncreased plasma leptinIncreased food intakeGain body weight

Summary

Leptin Resistance

Page 15: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Objectives

Leptin Resistance

Obese

Insulin Resistance

Diabetes

To understand molecular pathology of obesity and diabetes

1. Leptin Resistance as a mechanism of obesity2. Insulin Resistance as a mechanism of diabetes3. Metaflammation link between obesity and diabetes

Metaflammation

Page 16: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Diabetes

Diabetes is a metabolic diseases in which a person has high blood glucose.

Diabetes causes heart diseases, kidney failure and eye problem.

Page 17: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Insulin Resistance causes type II diabetes

Insulin resistance is defined as a deteriorated response to insulin action.

Individuals with insulin resistance are predisposed to developing type 2 diabetes.

Insulin resistance is a crucial pathological feature in the type 2 diabetes.

Page 18: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

InsulinA peptide hormone secreted from the Pancreas

Page 19: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Insulin actionGlucose

http://trialx.com/curetalk/2011/01/risk-of-cvd-in-diabetes-mellitus-pateints/

Page 20: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Molecular pathology of insulin resistance

Insulin

IRSPI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Page 21: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Hyperglycemia in insulin resistanceInsulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Duan et al, MCB, 2004

Insulin Resistance Insulin Resistance

Page 22: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Glucose tolerance and insulin sensitivity are impaired in insulin resistance

Insulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Duan et al, MCB, 2004

Insulin Resistance

Insulin Resistance

Glucose

Page 23: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Insulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Duan et al, MCB, 2004

Insulin Resistance

Insulin-induced insulin receptor phosphorylation is impaired in insulin resistance

Page 24: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Insulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Duan et al, MCB, 2004

Insulin Resistance

Insulin-induced insulin receptor substrate (IRS) phosphorylation is impaired in insulin resistance

Page 25: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Insulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Duan et al, MCB, 2004

Insulin Resistance

Insulin-induced PI3K activation is impaired in insulin resistance

PIP3: Phosphatidylinositol triphosphate

PIP3

Page 26: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Insulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Duan et al, MCB, 2004

Insulin ResistanceInsulin Insulin(-)(-)

Insulin-induced Akt phosphorylation is impaired in insulin resistance

Page 27: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Plasma insulin is elevated in insulin resistanceInsulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Duan et al, MCB, 2004

Insulin ResistanceInsulin Resistance

Page 28: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Insulin

IRS

PI3K

Plasma membrane

P P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

Impaired cellular Insulin signalingImpaired insulin-induced glucose uptakeImpaired glucose toleranceIncreased plasma Insulin

Summary

Insulin Resistance

Page 29: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Objectives

Leptin Resistance

Obese

Insulin Resistance

Diabetes

To understand molecular pathology of obesity and diabetes

1. Leptin Resistance as a mechanism of obesity2. Insulin Resistance as a mechanism of diabetes3. Metaflammation link between obesity and diabetes

Metaflammation

Page 30: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Inflammatory Reaction

http://jem.rupress.org/content/203/2/269/F2.large.jpg

Page 31: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Inflammatory Signaling

http://atlasgeneticsoncology.org/Deep/NFKBID20033.html

Page 32: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Metaflammation link between obese and diabetes

Metabolically driven, chronic low-grade of inflammation, termed metaflammation, takes place in obese conditions.

JNK

Plasma membrane

Inflammatory cytokinese.g. TNF-a, IL-6

Proinflammatory genes

NFkB

Stress response

Receptors

Nucleus

Inflammatory reactionsHost Defense

Page 33: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Inflammatory reaction inhibits insulin signaling

Insulin

IRSPI3KP P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

JNK

Inflammatory cytokinese.g. TNF-a, IL-6

Inhibitory phosphorylation

Receptors

P

Obese conditions

?

Hirosumi et al, Nature, 420, 333

Page 34: Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543

Metaflammation

Insulin

IRSPI3KP P AKT

Insulin Receptor

P PDK1

PIP3

P

Glut4

ER

Glucose

JNK

Inflammatory cytokinese.g. TNF-a, IL-6

Inhibitory phosphorylation

Receptors

P

Obese conditions

?

Summary

Chronic low-grade of inflammation, termed metaflammation, takes place in obese conditions.

The metaflammation causes insulin resistance partly through inhibitory phosphoryalation of IRS